查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1566761

免疫诊断市场：按产品类型、技术、应用和最终用户划分：2024-2033 年全球机会分析和产业预测

Immunodiagnostics Market By Product Type , By Technology By Application By End-user : Global Opportunity Analysis and Industry Forecast, 2024-2033
出版日期: | 出版商: Allied Market Research | 英文 280 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年免疫诊断市值为242亿美元，预计2024年至2033年复合年增长率为4.1%，到2033年达到364亿美元。

免疫诊断是一种利用抗原抗体反应来识别、标靶化和消除病原体和异物的测试。它是检测多种目标的强大技术，因此在感染疾病和自体免疫疾病检测、食品安全和癌症诊断领域有重要应用。最常见的免疫诊断技术包括酵素结合免疫吸附检测法（ELISA）、免疫测量、萤光免疫分析和横向流动化验。

全球免疫诊断市场的成长主要是由癌症、心血管疾病和胃肠道疾病等慢性疾病盛行率的惊人成长所推动的。此外，日益严重的环境污染以及由于高污染导致的疾病发病率上升正在推动对免疫诊断的需求。免疫诊断工具在二氯二苯基三氯乙烷 (DDT)、多氯联苯 (PCB)、爆炸物、有机磷农药和生物战剂等环境污染物的检测中发挥重要作用。此外，食品中的污染物（例如葡萄球菌肠毒素 B）以及水果、蔬菜和谷物中的农药也可以使用免疫诊断方法轻鬆检测。然而，与免疫诊断相关的高成本以及新兴国家不愿采用先进技术预计将阻碍市场成长。同时，人们对先进预防医学的认识不断提高，诊断试剂套件、检测方法和分析设备的技术进步预计将为预测期内全球免疫诊断市场的扩张提供利润丰厚的机会。

全球免疫诊断市场分为产品类型、技术、应用、最终用户和地区。依产品类型划分，市场分为试剂、仪器、软体和服务。依技术类型，市场分为酵素结合免疫吸附检测法、化学冷光免疫检测、萤光免疫分析、免疫检测等。依应用细分为感染疾病、肿瘤/内分泌、骨骼/矿物质疾病、自体免疫疾病、心臟生物标记、药物监测等。依最终使用者分为医院、临床检测实验室、学术/研究机构等。按地区划分，分为北美、欧洲、亚太地区和拉丁美洲/中东/非洲。

主要发现

按产品类型划分，预计到 2033 年试剂领域将引领市场。

从技术来看，ELISA技术领域将在2023年主导免疫诊断市场。

从应用来看，感染疾病领域可能在预测期内主导市场。

从最终用户来看，临床试验领域可能会在预测期内取得进展。

按地区划分，北美是 2023 年的主要收益来源，在预测期内也可能主导市场。

可以使用此报告进行客製化（需要额外费用和时间表）

  • 国家、区域和全球各级的患者/流行病学资料
  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 扩大公司简介列表
  • 历史市场资料
  • SWOT分析

目录

第一章简介

第 2 章执行摘要

第三章 市场状况

  • 市场定义和范围
  • 主要发现
    • 关键投资机会
    • 关键成功策略
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章免疫诊断市场：依产品类型

  • 市场概况
  • 试剂
  • 检测设备
  • 软体和服务

第五章免疫诊断市场：依技术分类

  • 市场概况
  • 酵素结合免疫吸附检测法
  • 化学冷光免疫检测
  • 萤光免疫分析
  • 免疫测量
  • 其他的

第六章免疫诊断市场：依应用分类

  • 市场概况
  • 感染疾病
  • 肿瘤科 内分泌科
  • 骨矿物质疾病
  • 自体免疫疾病
  • 心臟生物标记
  • 药物监测
  • 其他的

第七章免疫诊断市场：依最终使用者分类

  • 市场概况
  • 医院
  • 临床研究所
  • 学术研究所
  • 其他的

第八章免疫诊断市场：按地区

  • 市场概况
  • 北美洲
    • 主要市场趋势和机会
    • 美国免疫诊断市场
    • 加拿大免疫诊断市场
    • 墨西哥免疫诊断市场
  • 欧洲
    • 主要市场趋势和机会
    • 法国免疫诊断市场
    • 德国免疫诊断市场
    • 义大利免疫诊断市场
    • 西班牙免疫诊断市场
    • 英国免疫诊断市场
    • 其他欧洲免疫诊断市场
  • 亚太地区
    • 主要市场趋势和机会
    • 中国免疫诊断市场
    • 日本免疫诊断市场
    • 印度免疫诊断市场
    • 韩国免疫诊断市场
    • 澳洲免疫诊断市场
    • 其他亚太免疫诊断市场
  • 拉丁美洲/中东/非洲
    • 主要市场趋势和机会
    • 巴西免疫诊断市场
    • 南非免疫诊断市场
    • 沙乌地阿拉伯免疫诊断市场
    • 其他拉丁美洲/中东/非洲免疫诊断市场

第9章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 主要企业定位（2023年）

第十章 公司简介

  • Abbott
  • Becton Dickinson
  • Agilent Technologies, Inc.
  • Exact Sciences Corporation
  • Guardant Health
  • Illumina, Inc.
  • Diaosorin
  • NeoGenomics Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Thermo Fisher Scientific Inc.
简介目录
Product Code: A01435

The immunodiagnostics market was valued at $24.2 billion in 2023, and is projected to reach $36.4 billion by 2033, growing at a CAGR of 4.1% from 2024 to 2033.

Immunodiagnostics are tests that involve the use of antigen-antibody responses to identify, target, and eliminate pathogens or foreign substances. It serves as a powerful technique to detect a wide range of targets and thus finds its major application in the fields of infectious diseases and autoimmune disease detection, food safety, and cancer diagnostics. The most common Immunodiagnostics techniques include enzyme-linked immunosorbent assay (ELISA), radioimmunoassays, fluorescent immunoassays, and lateral flow assays.

The growth of the global immunodiagnostics market is majorly driven by alarming increase in prevalence of chronic diseases such as cancer, cardiovascular diseases, gastrointestinal disorders, and other chronic diseases due to vulnerability of geriatric population to such diseases and changes in lifestyle. Furthermore, increase in environmental pollution and rise in incidence of diseases due to high exposure to pollution have boosted the demand for immunodiagnostics. Immunodiagnostic tools play a key role in detecting environmental contaminants such as dichlorodiphenyltrichloroethane (DDT), polychlorinated biphenyls (PCB), explosives, organophosphorus pesticides, and biological warfare materials. In addition, contaminants in food such as Staphylococcal enterotoxin B as well as pesticides in fruits, vegetables, and grains can be easily detected using immunodiagnostics. However, high costs associated with immunodiagnostics and reluctance in the adoption of advanced technologies in emerging economies are expected to hamper the growth of the market. On the contrary, increase in awareness about advanced preventative health measures and technologically advancements in diagnostic kits, assays, and analyzers are expected to offer remunerative opportunities for the expansion of the global immunodiagnostics market during the forecast period.

The global immunodiagnostics market is segmented into product type, technology, application, end user, and region. Depending on product type, the market is classified into reagents, instruments, and software & services.?As per technology, it is segregated into enzyme-linked immunosorbent assay, chemiluminescence immunoassay, fluorescent immunoassay, radioimmunoassay, and others. Depending on application, it is fragmented into infectious diseases, oncology & endocrinology, bone & mineral diseases, autoimmunity disorders, cardiac biomarkers, drug monitoring, and others. By end user, it is categorized into hospitals, clinical laboratories, academic & research institutes, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of product type, the reagents segment is expected to lead the market by 2033.

As per technology, the ELISA technology segment dominated the immunodiagnostics market in 2023.

Depending on application, the infectious disease segment is likely to dominate the market during the forecast period.

By end user, the clinical laboratories segment is likely to be lucrative during the forecast period.

Region wise, North America was the major revenue generator in 2023, and is likely to dominate the market during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global immunodiagnostics market include Abbott, Becton Dickinson, Agilent Technologies, Inc., Exact Sciences Corporation, Guardant Health, Illumina, Inc., Diaosorin, NeoGenomics Laboratories, F. Hoffmann-La Roche Ltd., and Thermo Fisher Scientific. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the global market.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Product Type

  • Reagents
  • Instruments
  • Software and Services

By Technology

  • Enzyme-linked immunosorbent assay
  • Chemiluminescence immunoassay
  • Fluorescent immunoassay
  • Radioimmunoassay
  • Others

By Application

  • Infectious diseases
  • Oncology endocrinology
  • Bone mineral diseases
  • Autoimmunity disorders
  • Cardiac biomarkers
  • Drug monitoring
  • Others

By End-user

  • Hospitals
  • Clinical Laboratories
  • Academic research institutes
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • UK
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Africa
    • Saudi Arabia
    • Rest of LAMEA

Key Market Players:

    • Abbott
    • Becton Dickinson
    • Agilent Technologies, Inc.
    • Exact Sciences Corporation
    • Guardant Health
    • Illumina, Inc.
    • Diaosorin
    • NeoGenomics Laboratories
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report Description
  • 1.2. Key Market Segments
  • 1.3. Key Benefits
  • 1.4. Research Methodology
    • 1.4.1. Primary Research
    • 1.4.2. Secondary Research
    • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

  • 3.1. Market Definition and Scope
  • 3.2. Key Findings
    • 3.2.1. Top Investment Pockets
    • 3.2.2. Top Winning Strategies
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Bargaining Power of Suppliers
    • 3.3.2. Threat of New Entrants
    • 3.3.3. Threat of Substitutes
    • 3.3.4. Competitive Rivalry
    • 3.3.5. Bargaining Power among Buyers
  • 3.4. Market Dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: IMMUNODIAGNOSTICS MARKET, BY PRODUCT TYPE

  • 4.1. Market Overview
    • 4.1.1 Market Size and Forecast, By Product Type
  • 4.2. Reagents
    • 4.2.1. Key Market Trends, Growth Factors and Opportunities
    • 4.2.2. Market Size and Forecast, By Region
    • 4.2.3. Market Share Analysis, By Country
  • 4.3. Instruments
    • 4.3.1. Key Market Trends, Growth Factors and Opportunities
    • 4.3.2. Market Size and Forecast, By Region
    • 4.3.3. Market Share Analysis, By Country
  • 4.4. Software And Services
    • 4.4.1. Key Market Trends, Growth Factors and Opportunities
    • 4.4.2. Market Size and Forecast, By Region
    • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: IMMUNODIAGNOSTICS MARKET, BY TECHNOLOGY

  • 5.1. Market Overview
    • 5.1.1 Market Size and Forecast, By Technology
  • 5.2. Enzyme-linked Immunosorbent Assay
    • 5.2.1. Key Market Trends, Growth Factors and Opportunities
    • 5.2.2. Market Size and Forecast, By Region
    • 5.2.3. Market Share Analysis, By Country
  • 5.3. Chemiluminescence Immunoassay
    • 5.3.1. Key Market Trends, Growth Factors and Opportunities
    • 5.3.2. Market Size and Forecast, By Region
    • 5.3.3. Market Share Analysis, By Country
  • 5.4. Fluorescent Immunoassay
    • 5.4.1. Key Market Trends, Growth Factors and Opportunities
    • 5.4.2. Market Size and Forecast, By Region
    • 5.4.3. Market Share Analysis, By Country
  • 5.5. Radioimmunoassay
    • 5.5.1. Key Market Trends, Growth Factors and Opportunities
    • 5.5.2. Market Size and Forecast, By Region
    • 5.5.3. Market Share Analysis, By Country
  • 5.6. Others
    • 5.6.1. Key Market Trends, Growth Factors and Opportunities
    • 5.6.2. Market Size and Forecast, By Region
    • 5.6.3. Market Share Analysis, By Country

CHAPTER 6: IMMUNODIAGNOSTICS MARKET, BY APPLICATION

  • 6.1. Market Overview
    • 6.1.1 Market Size and Forecast, By Application
  • 6.2. Infectious Diseases
    • 6.2.1. Key Market Trends, Growth Factors and Opportunities
    • 6.2.2. Market Size and Forecast, By Region
    • 6.2.3. Market Share Analysis, By Country
  • 6.3. Oncology Endocrinology
    • 6.3.1. Key Market Trends, Growth Factors and Opportunities
    • 6.3.2. Market Size and Forecast, By Region
    • 6.3.3. Market Share Analysis, By Country
  • 6.4. Bone Mineral Diseases
    • 6.4.1. Key Market Trends, Growth Factors and Opportunities
    • 6.4.2. Market Size and Forecast, By Region
    • 6.4.3. Market Share Analysis, By Country
  • 6.5. Autoimmunity Disorders
    • 6.5.1. Key Market Trends, Growth Factors and Opportunities
    • 6.5.2. Market Size and Forecast, By Region
    • 6.5.3. Market Share Analysis, By Country
  • 6.6. Cardiac Biomarkers
    • 6.6.1. Key Market Trends, Growth Factors and Opportunities
    • 6.6.2. Market Size and Forecast, By Region
    • 6.6.3. Market Share Analysis, By Country
  • 6.7. Drug Monitoring
    • 6.7.1. Key Market Trends, Growth Factors and Opportunities
    • 6.7.2. Market Size and Forecast, By Region
    • 6.7.3. Market Share Analysis, By Country
  • 6.8. Others
    • 6.8.1. Key Market Trends, Growth Factors and Opportunities
    • 6.8.2. Market Size and Forecast, By Region
    • 6.8.3. Market Share Analysis, By Country

CHAPTER 7: IMMUNODIAGNOSTICS MARKET, BY END-USER

  • 7.1. Market Overview
    • 7.1.1 Market Size and Forecast, By End-user
  • 7.2. Hospitals
    • 7.2.1. Key Market Trends, Growth Factors and Opportunities
    • 7.2.2. Market Size and Forecast, By Region
    • 7.2.3. Market Share Analysis, By Country
  • 7.3. Clinical Laboratories
    • 7.3.1. Key Market Trends, Growth Factors and Opportunities
    • 7.3.2. Market Size and Forecast, By Region
    • 7.3.3. Market Share Analysis, By Country
  • 7.4. Academic Research Institutes
    • 7.4.1. Key Market Trends, Growth Factors and Opportunities
    • 7.4.2. Market Size and Forecast, By Region
    • 7.4.3. Market Share Analysis, By Country
  • 7.5. Others
    • 7.5.1. Key Market Trends, Growth Factors and Opportunities
    • 7.5.2. Market Size and Forecast, By Region
    • 7.5.3. Market Share Analysis, By Country

CHAPTER 8: IMMUNODIAGNOSTICS MARKET, BY REGION

  • 8.1. Market Overview
    • 8.1.1 Market Size and Forecast, By Region
  • 8.2. North America
    • 8.2.1. Key Market Trends and Opportunities
    • 8.2.2. Market Size and Forecast, By Product Type
    • 8.2.3. Market Size and Forecast, By Technology
    • 8.2.4. Market Size and Forecast, By Application
    • 8.2.5. Market Size and Forecast, By End-user
    • 8.2.6. Market Size and Forecast, By Country
    • 8.2.7. U.S. Immunodiagnostics Market
      • 8.2.7.1. Market Size and Forecast, By Product Type
      • 8.2.7.2. Market Size and Forecast, By Technology
      • 8.2.7.3. Market Size and Forecast, By Application
      • 8.2.7.4. Market Size and Forecast, By End-user
    • 8.2.8. Canada Immunodiagnostics Market
      • 8.2.8.1. Market Size and Forecast, By Product Type
      • 8.2.8.2. Market Size and Forecast, By Technology
      • 8.2.8.3. Market Size and Forecast, By Application
      • 8.2.8.4. Market Size and Forecast, By End-user
    • 8.2.9. Mexico Immunodiagnostics Market
      • 8.2.9.1. Market Size and Forecast, By Product Type
      • 8.2.9.2. Market Size and Forecast, By Technology
      • 8.2.9.3. Market Size and Forecast, By Application
      • 8.2.9.4. Market Size and Forecast, By End-user
  • 8.3. Europe
    • 8.3.1. Key Market Trends and Opportunities
    • 8.3.2. Market Size and Forecast, By Product Type
    • 8.3.3. Market Size and Forecast, By Technology
    • 8.3.4. Market Size and Forecast, By Application
    • 8.3.5. Market Size and Forecast, By End-user
    • 8.3.6. Market Size and Forecast, By Country
    • 8.3.7. France Immunodiagnostics Market
      • 8.3.7.1. Market Size and Forecast, By Product Type
      • 8.3.7.2. Market Size and Forecast, By Technology
      • 8.3.7.3. Market Size and Forecast, By Application
      • 8.3.7.4. Market Size and Forecast, By End-user
    • 8.3.8. Germany Immunodiagnostics Market
      • 8.3.8.1. Market Size and Forecast, By Product Type
      • 8.3.8.2. Market Size and Forecast, By Technology
      • 8.3.8.3. Market Size and Forecast, By Application
      • 8.3.8.4. Market Size and Forecast, By End-user
    • 8.3.9. Italy Immunodiagnostics Market
      • 8.3.9.1. Market Size and Forecast, By Product Type
      • 8.3.9.2. Market Size and Forecast, By Technology
      • 8.3.9.3. Market Size and Forecast, By Application
      • 8.3.9.4. Market Size and Forecast, By End-user
    • 8.3.10. Spain Immunodiagnostics Market
      • 8.3.10.1. Market Size and Forecast, By Product Type
      • 8.3.10.2. Market Size and Forecast, By Technology
      • 8.3.10.3. Market Size and Forecast, By Application
      • 8.3.10.4. Market Size and Forecast, By End-user
    • 8.3.11. UK Immunodiagnostics Market
      • 8.3.11.1. Market Size and Forecast, By Product Type
      • 8.3.11.2. Market Size and Forecast, By Technology
      • 8.3.11.3. Market Size and Forecast, By Application
      • 8.3.11.4. Market Size and Forecast, By End-user
    • 8.3.12. Rest of Europe Immunodiagnostics Market
      • 8.3.12.1. Market Size and Forecast, By Product Type
      • 8.3.12.2. Market Size and Forecast, By Technology
      • 8.3.12.3. Market Size and Forecast, By Application
      • 8.3.12.4. Market Size and Forecast, By End-user
  • 8.4. Asia-Pacific
    • 8.4.1. Key Market Trends and Opportunities
    • 8.4.2. Market Size and Forecast, By Product Type
    • 8.4.3. Market Size and Forecast, By Technology
    • 8.4.4. Market Size and Forecast, By Application
    • 8.4.5. Market Size and Forecast, By End-user
    • 8.4.6. Market Size and Forecast, By Country
    • 8.4.7. China Immunodiagnostics Market
      • 8.4.7.1. Market Size and Forecast, By Product Type
      • 8.4.7.2. Market Size and Forecast, By Technology
      • 8.4.7.3. Market Size and Forecast, By Application
      • 8.4.7.4. Market Size and Forecast, By End-user
    • 8.4.8. Japan Immunodiagnostics Market
      • 8.4.8.1. Market Size and Forecast, By Product Type
      • 8.4.8.2. Market Size and Forecast, By Technology
      • 8.4.8.3. Market Size and Forecast, By Application
      • 8.4.8.4. Market Size and Forecast, By End-user
    • 8.4.9. India Immunodiagnostics Market
      • 8.4.9.1. Market Size and Forecast, By Product Type
      • 8.4.9.2. Market Size and Forecast, By Technology
      • 8.4.9.3. Market Size and Forecast, By Application
      • 8.4.9.4. Market Size and Forecast, By End-user
    • 8.4.10. South Korea Immunodiagnostics Market
      • 8.4.10.1. Market Size and Forecast, By Product Type
      • 8.4.10.2. Market Size and Forecast, By Technology
      • 8.4.10.3. Market Size and Forecast, By Application
      • 8.4.10.4. Market Size and Forecast, By End-user
    • 8.4.11. Australia Immunodiagnostics Market
      • 8.4.11.1. Market Size and Forecast, By Product Type
      • 8.4.11.2. Market Size and Forecast, By Technology
      • 8.4.11.3. Market Size and Forecast, By Application
      • 8.4.11.4. Market Size and Forecast, By End-user
    • 8.4.12. Rest of Asia-Pacific Immunodiagnostics Market
      • 8.4.12.1. Market Size and Forecast, By Product Type
      • 8.4.12.2. Market Size and Forecast, By Technology
      • 8.4.12.3. Market Size and Forecast, By Application
      • 8.4.12.4. Market Size and Forecast, By End-user
  • 8.5. LAMEA
    • 8.5.1. Key Market Trends and Opportunities
    • 8.5.2. Market Size and Forecast, By Product Type
    • 8.5.3. Market Size and Forecast, By Technology
    • 8.5.4. Market Size and Forecast, By Application
    • 8.5.5. Market Size and Forecast, By End-user
    • 8.5.6. Market Size and Forecast, By Country
    • 8.5.7. Brazil Immunodiagnostics Market
      • 8.5.7.1. Market Size and Forecast, By Product Type
      • 8.5.7.2. Market Size and Forecast, By Technology
      • 8.5.7.3. Market Size and Forecast, By Application
      • 8.5.7.4. Market Size and Forecast, By End-user
    • 8.5.8. South Africa Immunodiagnostics Market
      • 8.5.8.1. Market Size and Forecast, By Product Type
      • 8.5.8.2. Market Size and Forecast, By Technology
      • 8.5.8.3. Market Size and Forecast, By Application
      • 8.5.8.4. Market Size and Forecast, By End-user
    • 8.5.9. Saudi Arabia Immunodiagnostics Market
      • 8.5.9.1. Market Size and Forecast, By Product Type
      • 8.5.9.2. Market Size and Forecast, By Technology
      • 8.5.9.3. Market Size and Forecast, By Application
      • 8.5.9.4. Market Size and Forecast, By End-user
    • 8.5.10. Rest of LAMEA Immunodiagnostics Market
      • 8.5.10.1. Market Size and Forecast, By Product Type
      • 8.5.10.2. Market Size and Forecast, By Technology
      • 8.5.10.3. Market Size and Forecast, By Application
      • 8.5.10.4. Market Size and Forecast, By End-user

CHAPTER 9: COMPETITIVE LANDSCAPE

  • 9.1. Introduction
  • 9.2. Top Winning Strategies
  • 9.3. Product Mapping of Top 10 Player
  • 9.4. Competitive Dashboard
  • 9.5. Competitive Heatmap
  • 9.6. Top Player Positioning, 2023

CHAPTER 10: COMPANY PROFILES

  • 10.1. Abbott
    • 10.1.1. Company Overview
    • 10.1.2. Key Executives
    • 10.1.3. Company Snapshot
    • 10.1.4. Operating Business Segments
    • 10.1.5. Product Portfolio
    • 10.1.6. Business Performance
    • 10.1.7. Key Strategic Moves and Developments
  • 10.2. Becton Dickinson
    • 10.2.1. Company Overview
    • 10.2.2. Key Executives
    • 10.2.3. Company Snapshot
    • 10.2.4. Operating Business Segments
    • 10.2.5. Product Portfolio
    • 10.2.6. Business Performance
    • 10.2.7. Key Strategic Moves and Developments
  • 10.3. Agilent Technologies, Inc.
    • 10.3.1. Company Overview
    • 10.3.2. Key Executives
    • 10.3.3. Company Snapshot
    • 10.3.4. Operating Business Segments
    • 10.3.5. Product Portfolio
    • 10.3.6. Business Performance
    • 10.3.7. Key Strategic Moves and Developments
  • 10.4. Exact Sciences Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Key Executives
    • 10.4.3. Company Snapshot
    • 10.4.4. Operating Business Segments
    • 10.4.5. Product Portfolio
    • 10.4.6. Business Performance
    • 10.4.7. Key Strategic Moves and Developments
  • 10.5. Guardant Health
    • 10.5.1. Company Overview
    • 10.5.2. Key Executives
    • 10.5.3. Company Snapshot
    • 10.5.4. Operating Business Segments
    • 10.5.5. Product Portfolio
    • 10.5.6. Business Performance
    • 10.5.7. Key Strategic Moves and Developments
  • 10.6. Illumina, Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Key Executives
    • 10.6.3. Company Snapshot
    • 10.6.4. Operating Business Segments
    • 10.6.5. Product Portfolio
    • 10.6.6. Business Performance
    • 10.6.7. Key Strategic Moves and Developments
  • 10.7. Diaosorin
    • 10.7.1. Company Overview
    • 10.7.2. Key Executives
    • 10.7.3. Company Snapshot
    • 10.7.4. Operating Business Segments
    • 10.7.5. Product Portfolio
    • 10.7.6. Business Performance
    • 10.7.7. Key Strategic Moves and Developments
  • 10.8. NeoGenomics Laboratories
    • 10.8.1. Company Overview
    • 10.8.2. Key Executives
    • 10.8.3. Company Snapshot
    • 10.8.4. Operating Business Segments
    • 10.8.5. Product Portfolio
    • 10.8.6. Business Performance
    • 10.8.7. Key Strategic Moves and Developments
  • 10.9. F. Hoffmann-La Roche Ltd.
    • 10.9.1. Company Overview
    • 10.9.2. Key Executives
    • 10.9.3. Company Snapshot
    • 10.9.4. Operating Business Segments
    • 10.9.5. Product Portfolio
    • 10.9.6. Business Performance
    • 10.9.7. Key Strategic Moves and Developments
  • 10.10. Thermo Fisher Scientific Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Key Executives
    • 10.10.3. Company Snapshot
    • 10.10.4. Operating Business Segments
    • 10.10.5. Product Portfolio
    • 10.10.6. Business Performance
    • 10.10.7. Key Strategic Moves and Developments